NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies.
The index may include securities of large-, mid- and small-capitalization companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.89% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 7.58% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.57% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 6.19% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.46% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.85% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.08% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 2.02% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.87% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.85% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.66% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.60% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.46% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.43% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.42% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.40% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.39% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.29% |